FDA daily for Thursday, July 23, 2026
In this issue: 6 shortage updates and 17 approvals.
Drug shortages
FDA date:FDA updated 6 shortage entries on Wed, Jul 22: 6 status updates.
- Ketorolac Tromethamine Injection
Gland Pharma Limited · Available · Reason: Demand increase for the drug
- Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited · Available
- Furosemide Injection
Gland Pharma Limited · Unavailable · Reason: Discontinuation of the manufacture of the drug
- Etomidate Injection
Gland Pharma Limited · Available
- Metronidazole Injection
Gland Pharma Limited · Unavailable · Reason: Discontinuation of the manufacture of the drug
- Midazolam Hydrochloride Injection
Gland Pharma Limited · Unavailable · Reason: Other
Drug and biologic approvals
FDA date:On Thu, Jul 16 FDA approved 1 new application (0 brand or biologic, 1 generic) and 16 supplements to existing ones.
- HYDROCORTISONE
RISING · HYDROCORTISONE
FDA did not answer for Clearances, Labels, Food and supplement recalls, Device recalls while this issue was written; those sections will fill in on a later visit.
How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.